Enliven Therapeutics (ELVN) Return on Capital Employed [ROCE] (2020 - 2026)
Enliven Therapeutics' Return on Capital Employed [ROCE] was -18.48% in Q2 2026, up 10.97 percentage points from -29.44% a year earlier and up 6.75 percentage points from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Enliven Therapeutics came in at -31.13%, up 5.83 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +43.57 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -36.96% in FY2024 (+18.11 pp), -55.07% in FY2023 (-5.81 pp), -49.25% in FY2022 (+11.24 pp) and -60.50% in FY2021 (+14.20 pp).
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2020.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for five straight quarters, with an average year-over-year change of +3.97 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2023 (a gain of 45.30 percentage points); the worst was Q3 2021 (a drop of 21.47 percentage points).
- Per Business Quant data, ELVN's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -25.22% (Q1 2026), -25.63% (Q4 2025) and -23.26% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Enliven Therapeutics | 3.44 Bn | 3.44 Bn | - | -18.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.48% |
| Mar 31, 2026 | -25.22% |
| Dec 31, 2025 | -25.63% |
| Sep 30, 2025 | -23.26% |
| Jun 30, 2025 | -29.44% |
| Mar 31, 2025 | -36.73% |
| Dec 31, 2024 | -34.89% |
| Sep 30, 2024 | -33.55% |
| Jun 30, 2024 | -31.19% |
| Mar 31, 2024 | -32.98% |
| Dec 31, 2023 | -33.81% |
| Sep 30, 2023 | -26.36% |
| Jun 30, 2023 | -20.12% |
| Mar 31, 2023 | -25.55% |
| Dec 31, 2022 | -63.09% |
| Sep 30, 2022 | -71.52% |
| Jun 30, 2022 | -65.42% |
| Mar 31, 2022 | -61.99% |
| Dec 31, 2021 | -55.24% |
| Sep 30, 2021 | -58.94% |
API Access
Enliven Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();